fbpx
Skip To Content

Research News

Robert Lanza
Regenerative Medicine Milestone: Stem Cell Clinical Trial Announces Positive Results

Advanced Cell Technology (ACT), an early leader in the field of regenerative medicine, recently published data in The Lancet that shows positive results from its ongoing stem cell transplantation trial. The clinical trial uses…

Read More
Orly
A New Kind of Vision

How would you describe what it feels like to see something? We have lots of language to help us with this. We can talk about colours, textures, shadows, scenery, and movement. We…

Read More
Baby's Face
Discovery Paves Road for New Treatments to Prevent Blindness in Babies

Babies born with Retinopathy of prematurity (ROP), one of the most common causes of vision loss in children, stand to benefit from an exciting discovery made possible, in part, by Fighting Blindness Canada. The…

Read More
Laboratory Researchers
Valproic Acid as a Treatment for Retinitis Pigmentosa

Clinical trials of valproic acid for the treatment of retinitis pigmentosa began in both the USA and Korea in late 2011. As well, a smaller shorter open-label trial was begun in Japan….

Read More
Laboratory Researchers
One Year Results of Choroideremia Gene Therapy Trial

In January, follow-up results from the first six months of the British choroideremia gene therapy trial were published. At the Association for Vision Research and Ophthalmology meeting today, the team led by Dr. Robert…

Read More
Laboratory Researchers
First Gene Therapy Results for Choroideremia Suggest Cautious Optimism

The first human trial of a gene therapy for choroideremia has announced preliminary results on six people: two of these patients have experienced significant improvements in vision. The findings were published in…

Read More

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our eNews.

I have read and accepted the privacy policy